Patents for A61P 3 - Drugs for disorders of the metabolism (129,789)
04/2012
04/11/2012EP1532153B8 Azepinoindole and pyridoindole derivatives as pharmaceutical agents
04/11/2012EP1326840B1 Substituted heterocyclic compounds for treating multidrug resistance
04/11/2012EP1261590B1 Piperidine- and piperazine substituted n-hydroxyformamides as inhibitors of metalloproteinases
04/11/2012CN1856300B Neutral amino acid replenishers for treating conditions associated with metabolic disorders
04/11/2012CN102414191A 4 -isopropylphenyl glucitol compounds as sgltl inhibitors
04/11/2012CN102414180A 作为沉默调节蛋白调节剂的8-取代的喹啉及相关的类似物 As a sirtuin modulators 8-substituted quinoline and related analogs
04/11/2012CN102413828A 作为食欲素受体拮抗剂的噻唑烷-4-酮和[1,3]-噻嗪烷-4-酮化合物 Orexin receptor antagonists as thiazolidine-4-one and [1,3] - thiazine-4-one compound of
04/11/2012CN102413822A 提高哺乳动物中内源性缩醛磷脂水平的方法 Improved mammalian endogenous level of a plasmalogen
04/11/2012CN102408973A Rhizoma polygonati health wine and preparation method thereof
04/11/2012CN102408493A Sedum spectabile polysaccharide preparation method, and product and application thereof
04/11/2012CN102408459A Anomeric alkyl-containing phenyl C-glucoside derivative, preparation thereof and application
04/11/2012CN102408429A Condensed imidazolo derivatives for the inhibition of aldosterone synthase and aromatase
04/11/2012CN102408417A 2-取代乙烯磺酸酯类化合物及其制备方法和应用 2-substituted vinyl sulfonic acid ester compound and its preparation method and application
04/11/2012CN102408411A Hydroximic acid compound containing quinolyl and preparation method thereof, and drug composition containing the compound and use thereof
04/11/2012CN102406952A <sup>11</sup>C-碳酸氢盐注射液在制备酸碱失衡PET药物中的应用 <Sup> 11 </ sup> C- bicarbonate injection in the preparation of acid-base balance in the application of PET drugs
04/11/2012CN102406943A 人成纤维细胞生长因子-21的聚乙二醇化学修饰物及其制备方法 Polyethylene glycol chemically modified human adult material fibroblast growth factor-21 and its preparation method
04/11/2012CN102406860A 预防和治疗糖尿病的组合物、其制备方法及应用 Prevention and treatment of diabetes composition, its preparation method and application
04/11/2012CN102406836A 一种具有辅助降血糖功能的中药组合物及其制备方法 Having an auxiliary hypoglycemic medicine composition and its preparation method
04/11/2012CN102406832A 一种来源于牛蒡叶的绿原酸生态制剂 One kind from burdock leaf chlorogenic acid ecological preparations
04/11/2012CN102406809A 一种透皮吸收医治糖尿病膏药及制备方法 A transdermal absorption plaster treatment of diabetes and its preparation method
04/11/2012CN102406805A 一种减肥中药制剂 A weight loss medicine preparations
04/11/2012CN102406800A 治疗气阴两虚型糖尿病的中药制剂 Chinese medicine treatment of diabetes Qiyinliangxu
04/11/2012CN102406799A 治疗糖尿病高血压并发冠心病的巴布膏及其制备方法 Treatment of hypertension with diabetes, coronary heart disease and its preparation method Babu paste
04/11/2012CN102406796A 一种治疗老年肥胖的药物 A method of treating obesity drugs in elderly
04/11/2012CN102406771A 治疗高血脂的中药制剂 Chinese medicine treatment of high cholesterol
04/11/2012CN102406769A Traditional Chinese medicinal preparation for treating hypertension, hyperlipidemia, arteriosclerosis and coronary heart disease, and preparation method thereof
04/11/2012CN102406755A 一种辅助降糖的中药组合物 An auxiliary hypoglycemic herbal compositions
04/11/2012CN102406711A 一种治疗糖尿病的药物 Drugs for treating diabetes
04/11/2012CN102406696A New application of common aeschynomene herb and extract thereof
04/11/2012CN102406693A 一种双水相体系富集分离红车轴草异黄酮类物质的方法 A two-phase system of water enrichment and separation of red clover isoflavones methods
04/11/2012CN102406691A 一种钙与酸性植物药组合制片的方法 A calcium producer with an acidic herbal combination method
04/11/2012CN102406690A 一种中药绞股兰口含片 A traditional Chinese medicine Gynostemma buccal tablets
04/11/2012CN102406686A Ligand agents for peroxisome proliferator-activated receptors (ppars)
04/11/2012CN102406683A 一种多靶点起效的菊苣降糖有效部位的制备方法及用途 A multi-target onset chicory hypoglycemic effective part of the preparation method and use
04/11/2012CN102406671A Application of Chinese herbal medicine Folium llicis Latifoliae extract in preparation of weight-losing and fat-reducing medicine or preparation of medicine with lipase activity inhibition function
04/11/2012CN102406661A Composite mineral substance crystal for regulating blood fat and blood sugar
04/11/2012CN102406638A 尿囊素作为活性成分单独应用或用途 Allantoin alone or use as an active ingredient
04/11/2012CN102406635A 含有二乙酰大黄酸类化合物的药物及二乙酰大黄酸类化合物的包合物的制备方法 Preparation of inclusion compounds containing diacetyl rhubarb acids drugs and diacetyl compound rhubarb acids
04/11/2012CN102406624A 一种油茶皂苷控释片及其制备方法 One kind sasanquasaponin GITS its preparation method
04/11/2012CN102406622A Tolvaptan solid preparation
04/11/2012CN102406620A 一种骨架型洛伐他汀缓释微丸及其制备方法 One structure type lovastatin sustained-release pellets and its preparation method
04/11/2012CN102406604A 一种非诺贝特研磨悬浮液及其制备方法和应用 A non-abrasive suspension of fenofibrate and its preparation method and application
04/11/2012CN102406596A 硒代蛋氨酸溶液剂及其制备方法 Selenomethionine solution and its preparation method
04/11/2012CN102406594A 一种姜黄素鼻用凝胶剂及其制备方法和应用 One kind of curcumin nasal gel and its preparation method and application
04/11/2012CN102406593A A method for preparing a compressible tricalcium phosphate agglomerate and an oral preparation
04/11/2012CN102406163A 中药组合物在制备防治缓解体力疲劳保健食品或药品中的应用 Prevention and treatment of traditional Chinese medicine composition for the preparation of alleviating physical fatigue health food or drug application
04/11/2012CN101466687B Activating agent for peroxisome proliferator activated receptor delta
04/11/2012CN101427777B 一种保健降脂袋泡茶及其制备方法 A health teabag lowering its preparation method
04/11/2012CN101379044B 用于治疗糖尿病的杂双环磺酰胺衍生物 For the treatment of diabetes heterobicyclic sulfonamide derivatives
04/11/2012CN101374523B Dipeptidyl peptidase inhibitors for treating diabetes
04/11/2012CN101297851B 用于预防出生缺陷及改善记忆的药物组合物 For the prevention of birth defects and improving memory pharmaceutical composition
04/11/2012CN101085079B 一种用于治疗糖尿病的中药复方及其制备方法和应用 Traditional Chinese medicine and its preparation method and application for the treatment of diabetes
04/10/2012US8153806 Synthesis of 4-amino-thalidomide enantiomers
04/10/2012US8153690 Cycloalkyl-hydroxyl compounds and compositions for cholesterol management
04/10/2012US8153664 thrombosis, atherosclerosis, restenosis, hypertension, angina pectoris, arrhythmia, heart failures and cancer
04/10/2012US8153628 Pyrazolyl substituted xanthines
04/10/2012US8153625 Nitrogen-containing heterocyclic compounds and medicinal use thereof
04/10/2012US8153588 Methods useful in the treatment of bone resorption diseases
04/10/2012US8153117 Genetically altered chondrocyte expresses a therapeutic agent; implanting a biocompatible substrate into a target region; brain, heart, liver, kidney, intestinal tract, spleen, smooth and skeletal muscles, eye, ganglions, lungs, gonads, pancreas
04/10/2012US8153113 Method of increasing trafficking of endothelial progenitor cells to ischemia-damaged tissue
04/10/2012CA2632567C Medical uses of a selective estrogen receptor modulator in combination with sex steroid precursors
04/10/2012CA2497725C Pharmaceutical compositions as inhibitors of dipeptidyl peptidase-iv (dpp-iv)
04/10/2012CA2491802C Novel compounds, pharmaceutical compositions containing same, and methods of use for same
04/10/2012CA2484375C Oral dosage forms comprising fenofibrate
04/10/2012CA2445253C Single chain camelid vhh antibodies, method for their production in a mammal, and their uses
04/10/2012CA2401032C Memno peptides, a process for their preparation and their use
04/10/2012CA2378456C Albumin-binding compounds that prevent nonenzymatic glycation and that may be used for treatment of glycation-related pathologies
04/10/2012CA2353086C Pgc-1, a novel brown fat ppar.gamma. coactivator
04/10/2012CA2352573C Glp-1 analogues
04/05/2012WO2012043808A1 Heat shock protein expression inducer
04/05/2012WO2012043688A1 Enteral nutrient
04/05/2012WO2012043533A1 Antihuman ccr7 antibodies, hybridoma, nucleic acid, vector, cell, medicinal composition, and antibody-immobilized carrier
04/05/2012WO2012043505A1 Novel piperidine derivative and pharmaceutical containing same
04/05/2012WO2012042951A1 Atorbastatin-containing medicinal tablet
04/05/2012WO2012042433A1 N1-PYRAZOLOSPIROKETONE ACETYL-CoA CARBOXYLASE INHIBITORS
04/05/2012WO2012041898A1 Combination of sglt2 inhibitor and a sugar compound for the treatment of diabetes
04/05/2012WO2012041307A1 Composition and use thereof for reducing body weight and/or for improving stamina during, and regeneration after, performance of a physical activity
04/05/2012WO2012041158A1 Tricyclic compound, preparation method and pharmaceutical use thereof
04/05/2012WO2012041013A1 Polymorphs of 4-[2-dimethylamino-1-(1-hydroxycyclohexyl)ethyl]phenyl 4-methylbenzoate hydrochloride, methods for preparing the same and use of the same
04/05/2012WO2012006398A3 Combination immediate/delayed release delivery system for short half-life pharmaceuticals including remogliflozin
04/05/2012WO2012005536A3 Pharmaceutical compositions including carbamoyloxy arylalkanoyl arylpiperazine compound
04/05/2012WO2012004620A3 Use of deuterium depleted water for the treatment of insulin resistance
04/05/2012WO2011163389A3 Method for inducing fat loss in mammals
04/05/2012WO2011160974A3 Statin derivates and intermediates for their production
04/05/2012WO2011150279A3 Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of glutaminyl-trna synthetases
04/05/2012WO2011146410A3 Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of leucyl-trna synthetases
04/05/2012WO2011140135A3 Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of methionyl-trna synthetases
04/05/2012WO2011139799A3 Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of isoleucyl trna synthetases
04/05/2012WO2011139714A3 Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of cysteinyl-trna synthetase
04/05/2012WO2011121418A9 4 - aminopyrimidine derivatives and their as as adenosine a2a receptor antagonists
04/05/2012US20120084871 Npc1l1 orthologues
04/05/2012US20120083528 Novel protein kinase modulators and therapeutic uses thereof
04/05/2012US20120083525 Composition for preventing or treating obesity-related diseases mediated by the activation of ampk and including 2,5-bis-aryl-3,4-dimethyltetrahydrofuran lignans as active ingredients
04/05/2012US20120083522 Modulation of inflammatory responses by factor xi
04/05/2012US20120083517 Polymorphs of saxagliptin hydrochloride and processes for preparing them
04/05/2012US20120083504 Reverse Amide Compounds As Protein Deacetylase Inhibitors And Methods Of Use Thereof
04/05/2012US20120083499 Novel benzenesulfonamides as calcium channel blockers
04/05/2012US20120083495 Compounds for the treatment of spinal muscular atrophy and other uses
04/05/2012US20120083494 Novel triazole derivatives with improved receptor activity and bioavailability properties as ghrelin antagonists of growth hormone secretagogue receptors
04/05/2012US20120083492 Imidazopyrazines for use as kinase inhibitors